𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients

✍ Scribed by Crea, F.; Fornaro, L.; Paolicchi, E.; Masi, G.; Frumento, P.; Loupakis, F.; Salvatore, L.; Cremolini, C.; Schirripa, M.; Graziano, F.; Ronzoni, M.; Ricci, V.; Farrar, W. L.; Falcone, A.; Danesi, R.

Book ID
119962845
Publisher
Oxford University Press
Year
2012
Tongue
English
Weight
139 KB
Volume
23
Category
Article
ISSN
0923-7534

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Association of K-ras Mutational Status a
Association of K-ras Mutational Status and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Receiving Panitumumab Alone
✍ Daniel J. Freeman; Todd Juan; Maureen Reiner; J. Randolph Hecht; Neal J. Meropol πŸ“‚ Article πŸ“… 2008 πŸ› CIG Media Group, LP. 🌐 English βš– 502 KB

Background: Identifying predictive biomarkers is important to optimally treat patients. This analysis evaluated the association of K-ras, BRAF, and PIK3CA gene mutations with tumor resistance to panitumumab alone. Patients and Methods: From 3 phase II panitumumab metastatic colorectal cancer (mCRC)